Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Post by SamV21on May 22, 2022 2:00pm
126 Views
Post# 34701268

Qixleef is a dream that Guy does not have money to fund !

Qixleef is a dream that Guy does not have money to fund !Still waiting for 2020 , the breakout year remember .Guy said he was going to be selling Qixleef end of 2020 . Qixleef needs 100,000s of millions of dollars NOT 7 million .Not finished Phase 2 ,3 or 4 or final review , its all bs and hype and an over paid CEO scamming us all on his dream.Tetra has no drugs approved , the 2 DIn they had were sold off to keep the doors open and keep paying Guy , what the f are we paying 50 people at Tetra for again ?  , Tetra does not have the 50% they need to launch Reduvo IF Health Canada gives it a DIN number , copy and paste garbage all you want pumper on nothing trying to recover your .13 cents. 
<< Previous
Bullboard Posts
Next >>